Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057704 · ClinicalTrials.gov registry record · Phase 4
Comparison of Two Techniques of IV Lidocaine on Propofol Injection Pain
A Phase 4 study of Injections, Intravenous, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03057704 is a Phase 4 study of Injections, Intravenous that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03057704, a Phase 4 study of Injections, Intravenous, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Intravenous lidocaine is commonly given through an intravenous (IV) line prior to injection of propofol to reduce the amount of pain during propofol injection. The investigators want to study if giving the lidocaine through the IV while the forearm on the same limb has a tourniquet applied to it to prevent "washing out" of the lidocaine prior to propofol injection helps reduce propofol injection pain.
Conditions Studied
Interventions
- DRUG Lidocaine injection flushed
- DRUG Lidocaine injection tourniquet
Study Locations (1)
North Carolina
- North Carolina Baptist Hospital - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-12-05 |
| Est. Completion | 2017-01-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03057704
The ClinicalTrials.gov registry entry for NCT03057704 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Injections, Intravenous appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine injection flushed is the first listed.
NCT03057704 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03057704 about?
NCT03057704 is a clinical study titled "Comparison of Two Techniques of IV Lidocaine on Propofol Injection Pain". Intravenous lidocaine is commonly given through an intravenous (IV) line prior to injection of propofol to reduce the amount of pain during propofol injection. The investigators want to study if giving the lidocaine through the IV while the forearm on the same limb has a tourniquet applied to it to ...
What is the current status of trial NCT03057704?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2016-12-05. Estimated completion is 2017-01-20.
What conditions does trial NCT03057704 study?
This clinical trial studies the following conditions: Injections, Intravenous.
What interventions are being tested in trial NCT03057704?
The interventions under investigation include: Lidocaine injection flushed (DRUG), Lidocaine injection tourniquet (DRUG).
Who is sponsoring clinical trial NCT03057704?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03057704 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.